Preview

Comparison of Medtronic's Financial Statements to Baxter's Financial Statements

Good Essays
Open Document
Open Document
7654 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Comparison of Medtronic's Financial Statements to Baxter's Financial Statements
Medtronic 's Ratings
Earning Power

I would rank Medtronic 's earning power at a 9 on a scale of 1 (very weak) to 10 (very strong). Medtronic has successfully demonstrated their ability to grow and provide substantial return to their owners.
Medtronic 's net earnings have steadily increased from $984.0 million in 2002, to $1599.8 million in 2003, to $1959.3 million in 2004. Their total assets have increased 13.7% from $12,405.5 million in 2003 to $14,110.8 million in 2004. These measures show that Medtronic has been successful in generating profits and increasing their net assets. These measures have steadily been increasing and therefore this type of progress can reasonably be expected to persist in the future.
Total liabilities have also increased by 11.8% from $4,499.1 million in 2003 to $5,033.8 million in 2004. This can viewed as a way of financing the continued operations that support Medtronic 's success.
Medtronic paid $0.23 per share to owners in 2002. This amount equaled $278.8 million. In 2003, the company paid $0.25 per share, equal to $304.2 million. In 2004, the shareholders were paid $0.29 per share equaling $351.5 million. These amounts show that Medtronic has been paying substantial returns to its owners, and they have also been increasing the dividends paid per share.
Medtronic 's gross profit has increased from $4758.1 in 2002, to $5774.9 to 2003, to $6834.3 in 2004. The gross margin in 2004 was 75% showing that the selling price of the inventory exceeds the cost by 75%. This shows that Medtronic has been steadily earning profits from the sales of their products and services. Also, the receivable account was turned over 4.84 times in 2004 meaning that Medtronic has been receiving payment from its debtors and earning profits this way as well.
When looking at two of the profitability ratios, the return on equity and the return on assets, as compared to other leading companies in the industry, we can see that Medtronic is doing very

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Even though, the anticipated merger between Abbott and St. Jude Medical is an excellent opportunity, other recommendations that can improve the performance of St. Jude Medical is to continue to striving to develop quality products that improve consumers health. With more thorough clinical trials of all their new devices. As well as emphasizing and regulating more product recalls when issues with their brand…

    • 306 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Medtronic is a medical technology company engaged in manufacturing a range of medical devices and therapies. The company operates its business through seven segments that include cardiac rhythm disease management, spinal, cardiovascular, neuromodulation, diabetes, surgical technologies, and physio-control. It has operations in more than 120 countries. Medtronic is headquartered in Minneapolis, Minnesota and employed 43,000 people as of April 2010. The company recorded revenues of $15,817 million during the financial year (FY) ended April 2010, an increase of 8.3% over FY2009. The operating profit of the company was $4,215 million during FY2010, an increase of 60.7% over FY2009. The net profit of the company was $3,099 million in FY2010, an increase of 49.7% over FY2009.…

    • 602 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Revenue growth was equal to 12.6% in 2003 for a total amount of $7.24 billion. Its net income was the largest of the sector with $319.9 million. In the same time, and over the last three years, the Company has reduced its long-term debt by $448 million.…

    • 2345 Words
    • 10 Pages
    Powerful Essays
  • Better Essays

    Capital Justification

    • 937 Words
    • 4 Pages

    According to the hospital’s five-year plan, an investment in capital equipment should boost the quality of services offered at the hospital. Many options of capital investments that hospital could invest in exist. However, this report recommends an investment in the MRI (Magnetic Resonance Imaging) equipment. This equipment involves a large capital investment upfront, but it can be profitable in the end. The hospital has considered factors such as the cost of this equipment, the facilities needed, and the return on investment of the equipment. The above factors are among some of the factors that are considered when buying large capital equipment for an organization such as a hospital (Keefer, 2011).…

    • 937 Words
    • 4 Pages
    Better Essays
  • Satisfactory Essays

    On behalf of Baxter International Inc. (Baxter), ARCADIS has prepared this Feasibility Study (FS) and Interim Remedial Action Plan (IRAP) for Baxter Healthcare Corporation’s Medication Delivery Division facility located at 17511 Armstrong Avenue, Irvine, California (“the Site”). This FS/IRAP was prepared for submittal to the California Regional Water Quality Control Board (RWQCB), Santa Ana Region in accordance with the “Summary of April 13, 2010 Meeting” letter submitted to the RWQCB on April 23, 2010, which was subsequently approved in an email dated April 26, 2010 from Nick Amini, Ph.D., P.E., the current RWQCB case officer for the…

    • 98 Words
    • 1 Page
    Satisfactory Essays
  • Good Essays

    Merck Stock Market Game

    • 691 Words
    • 3 Pages

    Merck (MRK) experienced only minute changes over the period that I held onto it. During this time, Merck experienced both positives and negatives, and these different experiences helped to balance the value of the company’s stock. At the beginning of the year, Merck successfully “acquired IOmet,” a company that produces “innovative medicines for the treatment of cancer.” With this new subsidiary, Merck will most likely experience an increase in profits and control over this market. Therefore, this should have helped boost the stock. However, MRK did not grow, but it remained around the same; this was probably the result of a lawsuit. The drug company’s “illegal promotion of it former painkiller Vioxx.” This 800,000,000 dollar settlement most likely negated all the small gains that MRK had made over the past weeks. With these positives and negatives MRK’s value stayed relatively constant for the last couple of…

    • 691 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    According to 10-year total return diagram in the appendix, RIC’s total return is shown to have an overall under-market performance and thus, relatively low profitability. However, RIC’s profitability is increasing according to rising profitability ratios such as gross profit margin (from 9.53% to 10.35%), pre-tax profit margin (3.07% to 4.18%) and net profit margin (2.48% to 4.05%) in three-year basis of 2009-2011. Also, with an as-a-whole ROA increase from 3.19% to 5.81%, RIC is considered to be able to use its assets effectively to generate profit. Referring to Dupont analysis, ROE is the product of ROA and leverage ratio. Hence, the significant increase in ROE from 2009 (6.29%) to 2010 (10.37%) was mainly due to the growth in ROA from 3.19% to 6.11%, noting that leverage decreased from 1.97 to 1.70.…

    • 2819 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    Scitronics

    • 675 Words
    • 3 Pages

    4. SciTronics had $75000 of owners’ equity and earned $14000 after taxes in 2008. Its return on equity was 18.7 %, which represented an improvement from the 8.2 % earned in 2005.…

    • 675 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Which of the improvements in the new product development process that the Medtronic management team implemented strike or impress you as having been particularly crucial to turning the company around?…

    • 881 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Advanced Medical Corporation is experiencing significant growth; however, large expenditures in R&D and poor inventory and accounts receivables management process have resulted in negative earnings. By reducing the company’s spending, employing lower cost developing techniques, and adjusting the inventory and accounts receivables management process, AMT will be able to generate enough positive cash flow to pay off its debt and eventually increase its R&D expenditures.…

    • 1599 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    In order to identify possible issues that are interfering with Meditech’s ability to remain a leader in the endoscopic market, to understand clearly an analysis will be conducted to identify meditech’s problems in the introduction of new products, concerns in manufacturing, and all its products. The analysis will also observe how problems occur both systemically and organizationally, and the reason why the customer service manager pays quick attention to such problems. Furthermore, suggestions will be made in order to improve Meditech’s position and remain relative in the medical industry.…

    • 773 Words
    • 3 Pages
    Good Essays
  • Good Essays

    The legacy of Medtronic Corporation, the company that created the cardiac pacemaker industry, is a proud one. Starting from its earliest pacemakers, which had to be carried outside the body, Medtronic had achieved dramatic improvements in the functionality, size and reliability of these devices. In so doing it had extended the lives, and improved the quality of life, for hundreds of thousands of people in whom pacemakers had been implanted. The pacemaker has been designated as one of the ten most outstanding engineering achievements in the world over the past 50 years, along with the digital computer and the Apollo 11 moon landing. 1 Medtronic, which in 1995 booked operating profit of $300 million on revenues of $1.7 billion, had been founded in 1957 in Minneapolis, Minnesota by Earl Bakken, a researcher and inventor who had to his credit patents on several of the crucial technologies that led to the modern heart pacemaker. Pacemakers were small, battery-powered devices which, when implanted within a patient, helped a malfunctioning heart to beat in a steady, fixed rhythm. Because Medtronic was the first entrant into the pacemaker field and built a strong technological lead, it enjoyed a substantial portion (over 70%) of the market share for cardiac pacing through the 1960s. Building upon Medtronic’s legacy of leadership was not easy, however. In the face of increasing competition, rapid technological change and tightening market and regulatory demands for product quality, Medtronic saw its market share cut by more than half between 1970 and 1986. Though it had invested heavily in technology and product development over this period, much of that investment had been unproductive. Many projects failed to produce product designs that could be launched competitively, and the features and functionality of most of the products the company was able…

    • 8613 Words
    • 35 Pages
    Good Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs?…

    • 587 Words
    • 4 Pages
    Good Essays
  • Better Essays

    Cox Kings Financial Ratios

    • 2018 Words
    • 8 Pages

    Cox And Kings is the longest established travel company in the world, its history stretching back to 1758 when Richard Cox was appointed as regimental agent to the Foot Guards in India under the command of Lord Ligonier.…

    • 2018 Words
    • 8 Pages
    Better Essays
  • Powerful Essays

    *Assumption: RoE will be calculated using the profit and equity attributable to the equity holders of the parent (hence excluding NCI)…

    • 2083 Words
    • 9 Pages
    Powerful Essays